Top 2 dividend stocks to buy for long-term gains

Core Insights - Falling interest rates are leading money managers to shift towards income-oriented equities, particularly high-yield dividend stocks, as they offer yields above the S&P 500 [1] - The Federal Reserve may soon cut rates due to signs of a cooling labor market and core inflation, which is favorable for dividend stock investments [1] AbbVie (NYSE: ABBV) - AbbVie offers a dividend yield of 3.59% and has achieved a 10% annual dividend growth rate over the past five years, surpassing the 6% average among top dividend growers [2] - The stock trades at under 15 times forward earnings, making it attractively priced compared to the S&P 500's nearly 21 times forward earnings multiple [2] - Over the past five years, ABBV shares have appreciated by 117.71% [2] - AbbVie is managing the transition from the loss of market exclusivity for Humira, with strong sales from newer drugs like Skyrizi and Rinvoq, and Vraylar exceeding expectations [4][5] Pfizer (NYSE: PFE) - Pfizer has a dividend yield of 5.76% and is priced at less than 13 times future earnings, positioning it for potential outperformance over the next 10 to 20 years [6] - Despite trading below the S&P 500, Pfizer is a major player in the pharmaceutical industry with a promising pipeline [7] - PFE stock has declined by 29.17% over the past five years, primarily due to reduced revenue from COVID-19 product sales post-pandemic [8] - Pfizer's focus on oncology, which has strong pricing power, is often overlooked, but it remains a significant aspect of its long-term strategy [8] - Both AbbVie and Pfizer are suitable options for investors seeking high yields on long-term investments [8]